Cardiomyocyte-specific Estrogen Receptor Alpha Increases Angiogenesis, Lymphangiogenesis and Reduces Fibrosis in the Female Mouse Heart Post-Myocardial Infarction

Overview

Journal J Cell Sci Ther

Publisher Omics Publishing Group

Date 2014 Jul 1

PMID 24977106

Citations 32

Authors

Shokoufeh Mahmoodzadeh

Joachim Leber

Xiang Zhang

Frederic Jaisser

Smail Messaoudi

Ingo Morano

Priscilla A Furth

Elke Dworatzek

Vera Regitz-Zagrosek

Affiliations

Soon will be listed here.

Abstract

Experimental studies showed that 17β-estradiol (E2) and activated Estrogen Receptors (ER) protect the heart from ischemic injury. However, the underlying molecular mechanisms are not well understood. To investigate the role of ER-alpha (ERα) in cardiomyocytes in the setting of myocardial ischemia, we generated transgenic mice with cardiomyocyte-specific overexpression of ERα (ERα-OE) and subjected them to Myocardial Infarction (MI). At the basal level, female and male ERα-OE mice showed increased Left Ventricular (LV) mass, LV volume and cardiomyocyte length. Two weeks after MI, LV volume was significantly increased and LV wall thickness decreased in female and male WT-mice and male ERα-OE, but not in female ERα-OE mice. ERα-OE enhanced expression of angiogenesis and lymphangiogenesis markers (1), and neovascularization in the peri-infarct area in both sexes. However, attenuated level of fibrosis and higher phosphorylation of JNK signaling pathway could be detected only in female ERα-OE after MI. In conclusion, our study indicates that ERα protects female mouse cardiomyocytes from the sequelae of ischemia through induction of neovascularization in a paracrine fashion and impaired fibrosis, which together may contribute to the attenuation of cardiac remodelling.

Citing Articles

Sex Chromosomes and Sex Hormones: Dissecting the Forces That Differentiate Female and Male Hearts.

Brong A, Kontrogianni-Konstantopoulos A Circulation. 2025; 151(7):474-489.

PMID: 39960989 PMC: 11839176. DOI: 10.1161/CIRCULATIONAHA.124.069493.

Proteomic analysis reveals key differences in pro-stromal corneal tissue between highly myopic males and females.

Cui G, Di Y, Yang S, Chen Y, Li Y, Chen D Front Med (Lausanne). 2024; 11:1406748.

PMID: 39219796 PMC: 11361967. DOI: 10.3389/fmed.2024.1406748.

Lymphangiogenesis: A new strategy for heart disease treatment (Review).

Bai L, Wang Y, Du S, Si Y, Chen L, Li L Int J Mol Med. 2024; 53(4).

PMID: 38391009 PMC: 10903933. DOI: 10.3892/ijmm.2024.5359.

Cardiac and vascular complications in lupus: Is there a role for sex?.

Corker A, Learmonth M, Patrick D, DeLeon-Pennell K, Van Beusecum J Front Immunol. 2023; 14:1098383.

PMID: 37063843 PMC: 10090292. DOI: 10.3389/fimmu.2023.1098383.

Sex and gender differences in myocarditis and dilated cardiomyopathy: An update.

Fairweather D, Beetler D, Musigk N, Heidecker B, Lyle M, Cooper Jr L Front Cardiovasc Med. 2023; 10:1129348.

PMID: 36937911 PMC: 10017519. DOI: 10.3389/fcvm.2023.1129348.

References

Kim J, Pedram A, Razandi M, Levin E . Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms. J Biol Chem. 2006; 281(10):6760-7. DOI: 10.1074/jbc.M511024200. View

Laine G, Allen S . Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res. 1991; 68(6):1713-21. DOI: 10.1161/01.res.68.6.1713. View

Nordmeyer J, Eder S, Mahmoodzadeh S, Martus P, Fielitz J, Bass J . Upregulation of myocardial estrogen receptors in human aortic stenosis. Circulation. 2004; 110(20):3270-5. DOI: 10.1161/01.CIR.0000147610.41984.E8. View

Ropero A, Eghbali M, Minosyan T, Tang G, Toro L, Stefani E . Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen. J Mol Cell Cardiol. 2006; 41(3):496-510. DOI: 10.1016/j.yjmcc.2006.05.022. View

Mahmoodzadeh S, Eder S, Nordmeyer J, Ehler E, Huber O, Martus P . Estrogen receptor alpha up-regulation and redistribution in human heart failure. FASEB J. 2006; 20(7):926-34. DOI: 10.1096/fj.05-5148com. View

Jesmin S, Mowa C, Sultana S, Shimojo N, Togashi H, Iwashima Y . VEGF signaling is disrupted in the hearts of mice lacking estrogen receptor alpha. Eur J Pharmacol. 2010; 641(2-3):168-78. DOI: 10.1016/j.ejphar.2010.05.020. View

Mahmoodzadeh S, Dworatzek E, Fritschka S, Pham T, Regitz-Zagrosek V . 17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts. Cardiovasc Res. 2009; 85(4):719-28. PMC: 2819834. DOI: 10.1093/cvr/cvp350. View

Hamada H, Kim M, Iwakura A, Ii M, Thorne T, Qin G . Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation. 2006; 114(21):2261-70. DOI: 10.1161/CIRCULATIONAHA.106.631465. View

Hoeben A, Landuyt B, Highley M, Wildiers H, van Oosterom A, De Bruijn E . Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004; 56(4):549-80. DOI: 10.1124/pr.56.4.3. View

10.

Post W, Goldschmidt-Clermont P, Wilhide C, Heldman A, Sussman M, Ouyang P . Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 2000; 43(4):985-91. DOI: 10.1016/s0008-6363(99)00153-4. View

11.

Hale S, Birnbaum Y, Kloner R . beta-Estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J. 1996; 132(2 Pt 1):258-62. DOI: 10.1016/s0002-8703(96)90419-6. View

12.

Molkentin J, Dorn 2nd G . Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol. 2001; 63:391-426. DOI: 10.1146/annurev.physiol.63.1.391. View

13.

Westphal C, Schubert C, Prelle K, Penkalla A, Fliegner D, Petrov G . Effects of estrogen, an ERα agonist and raloxifene on pressure overload induced cardiac hypertrophy. PLoS One. 2012; 7(12):e50802. PMC: 3515519. DOI: 10.1371/journal.pone.0050802. View

14.

Xu Y, Armstrong S, Arenas I, Pehowich D, Davidge S . Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat. Am J Physiol Heart Circ Physiol. 2004; 287(1):H165-71. DOI: 10.1152/ajpheart.00037.2004. View

15.

Urbich C, Dimmeler S . Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int. 2005; 67(5):1672-6. DOI: 10.1111/j.1523-1755.2005.00261.x. View

16.

Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal J . Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation. 2001; 103(3):423-8. DOI: 10.1161/01.cir.103.3.423. View

17.

Witt H, Schubert C, Jaekel J, Fliegner D, Penkalla A, Tiemann K . Sex-specific pathways in early cardiac response to pressure overload in mice. J Mol Med (Berl). 2008; 86(9):1013-24. PMC: 2517094. DOI: 10.1007/s00109-008-0385-4. View

18.

Wagner N, Jehl-Pietri C, Lopez P, Murdaca J, Giordano C, Schwartz C . Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin. Cardiovasc Res. 2009; 83(1):61-71. DOI: 10.1093/cvr/cvp106. View

19.

Gagliardi A, Collins D . Inhibition of angiogenesis by antiestrogens. Cancer Res. 1993; 53(3):533-5. View

20.

Lee T, Lin M, Chou T, Tsai C, Chang N . Adjunctive 17beta-estradiol administration reduces infarct size by altered expression of canine myocardial connexin43 protein. Cardiovasc Res. 2004; 63(1):109-17. DOI: 10.1016/j.cardiores.2004.03.009. View